Evidence map›Paper›PMID 29925855›Full record

ArticleEuropean journal of human genetics : EJHG2018

De novo ITPR1 variants are a recurrent cause of early-onset ataxia, acting via loss of channel function.

Matthis Synofzik, Katherine L Helbig, Florian Harmuth, Tine Deconinck, Pranoot Tanpaiboon, Bo Sun, Wenting Guo, Ruiwu Wang, Erika Palmaer, Sha Tang and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. The novel ITPR1 p.Phe2566Ser variant impairs IPJournal of internal medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in neurology · 2024
    Article
  8. Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design.Movement disorders : official journal of the Movement Disorder Society · 2024
    Article
  9. Cold Spring Harbor molecular case studies · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Superior Cerebellar Atrophy: An Imaging Clue to DiagnoseInternational journal of molecular sciences · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Solving unsolved rare neurological diseases-a Solve-RD viewpoint.European journal of human genetics : EJHG · 2021
    Article
  19. A novel de novo intronic variant in ITPR1 causes Gillespie syndrome.American journal of medical genetics. Part A · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 4 countries.

Matthis SynofzikDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. matthis.synofzik@uni-tuebingen.de.ORCID http://orcid.org/0000-0002-2280-7273
Katherine L HelbigDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Florian HarmuthInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Tine DeconinckNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium.
Pranoot TanpaiboonDivision of Genetics and Metabolism, Children's National Health System, Washington, USA.
Bo SunLibin Cardiovascular Institute of Alberta, Departments of Physiology & Pharmacology, and Biochemistry & Molecular Biology, University of Calgary, Calgary, AB, T2N 4N1, Canada.
Wenting GuoLibin Cardiovascular Institute of Alberta, Departments of Physiology & Pharmacology, and Biochemistry & Molecular Biology, University of Calgary, Calgary, AB, T2N 4N1, Canada.
Ruiwu WangLibin Cardiovascular Institute of Alberta, Departments of Physiology & Pharmacology, and Biochemistry & Molecular Biology, University of Calgary, Calgary, AB, T2N 4N1, Canada.
Erika PalmaerDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Sha TangDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
G Bradley SchaeferDivision of Medical Genetics, University of Arkansas for Medical Sciences, Little Rock, USA.
Janina Gburek-AugustatDepartment of Neuropediatrics, Children's University Hospital, Tübingen, Germany.
Stephan ZüchnerDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, USA.
Ingeborg Krägeloh-MannDepartment of Neuropediatrics, Children's University Hospital, Tübingen, Germany.
Jonathan BaetsNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium.
Peter de JongheNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium.
Peter BauerInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
S R Wayne ChenLibin Cardiovascular Institute of Alberta, Departments of Physiology & Pharmacology, and Biochemistry & Molecular Biology, University of Calgary, Calgary, AB, T2N 4N1, Canada.
Ludger SchölsDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Rebecca SchüleDepartment of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
University of Calgary · CAAmbry Genetics (United States) · USGerman Center for Neurodegenerative Diseases · DEUniversity of Antwerp · BECentogene (Germany) · DEChildren's National · USMedizinische Hochschule Hannover · DEUniversity Children's Hospital Tübingen · DEUniversity of Arkansas for Medical Sciences · USUniversity of Miami · USUniversity of Tübingen · DE

Funding

trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
Genomic Studies in Charcot-Marie-Tooth DiseaseR01NS075764 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHY, MICHAEL E., ZUCHNER, STEPHAN · 2012 to 2016
$3.0M
Molecular And Genetic Analysis Of Autosomal Dominant Spastic ParaplegiaR01NS054132 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZUCHNER, STEPHAN · 2008 to 2011
$1.3M
NINDS NIH HHS R01 NS054132NINDS NIH HHS R01 NS072248NINDS NIH HHS R01 NS075764NINDS NIH HHS U54 NS065712
6 · The paper itself

Abstract

We explored the clinico-genetic basis of spinocerebellar ataxia 29 (SCA29) by determining the frequency, phenotype, and functional impact of ITPR1 missense variants associated with early-onset ataxia (EOA). Three hundred thirty one patients from a European EOA target cohort (n = 120), US-American EOA validation cohort (n = 72), and early-onset epileptic encephalopathy (EOEE) control cohort (n = 139) were screened for de novo ITPR1 variants. The target cohort was also screened for inherited ITPR1 variants. The variants' functional impact was determined by IP3-induced Ca

Indexed as

Loss of Function MutationCalciumChildFemaleHEK293 CellsHumansInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsMutation, MissenseSpinocerebellar DegenerationsCalciumInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsITPR1 protein, human

Identifiers

PMID29925855
PMCPMC6189112
OpenAlexW2808966885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.